ExpreS2ion Biotech Holding AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 1.45 million compared to SEK 0.833 million a year ago. Revenue was SEK 1.86 million compared to SEK 0.909 million a year ago. Net loss was SEK 21.83 million compared to SEK 30.7 million a year ago.
For the nine months, sales was SEK 5.94 million compared to SEK 4.11 million a year ago. Revenue was SEK 6.52 million compared to SEK 4.57 million a year ago. Net loss was SEK 78.17 million compared to SEK 70.07 million a year ago.